《睡眠專業人士雜誌》
星期六, 七月 25, 2026
Although there are more than half a billion individuals worldwide affected by moderate to severe obstructive sleep apnea (OSA), the vast majority still remain undiagnosed and many are untreated.1-2 Healthcare in the United States is facing shortages at every level—and these shortages are projected to increase sharply over the next […]
EnsoData announces the acquisition of sleep testing diagnostic technology from Resonea aimed at reducing the cost of systematically addressing sleep apnea across large patient populations. With this acquisition, EnsoData adds acoustic flow and microphone data channels to enable an exciting new way to pre-screen patients for sleep apnea with an […]
